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ABSTRACT
Objectives This study aimed to report the prevalence and 
clinical characteristics of adults with cerebral palsy (CP) in 
a geographically defined region of the UK.
Design and setting Cross- sectional study using the 
Northern Ireland Cerebral Palsy Register (NICPR).
Participants All validated cases known to the NICPR, born 
1981–2001 and alive and resident in Northern Ireland at 
age 19 years were included.
Results The study included 1218 persons with CP 
aged 19–39 years, 46 of whom died in adulthood. The 
prevalence of CP was 2.38 per 1000. The majority of 
cases had spastic CP (n=1132/1218, 93%) and could walk 
(n=949/1218, 78%). Those that died in adulthood typically 
had bilateral spastic CP (n=39/46) and used a wheelchair 
(n=40/46).
Conclusion The prevalence of CP in adults is similar to 
other common neurological conditions such as multiple 
sclerosis and Parkinson’s disease. The needs of adults 
with CP vary widely with almost half having two or more 
associated impairments that may require multiprofessional 
and multiagency coordination. Results from this study 
can be used to inform transformation of health and care 
services for adults with CP.
INTRODUCTION
Cerebral palsy (CP) is a complex condition 
that requires access to a range of health and 
social care services across the lifespan. While 
CP is not progressive,1 clinical features of 
the condition can change over time. Recent 
research has demonstrated that adults with 
CP experience secondary comorbidities and 
quicker declining mobility when compared 
with the general population.2 3 In addition, 
many adults with CP experience pain,2–5 
depression and anxiety,6 and are more 
likely to develop other chronic conditions, 
such as asthma, stroke, heart disease and 
arthritis.7 8 Coupled with this, an increasing 
number of severely impaired young people 
with CP are now surviving and transitioning 
to adult services.9 This highlights the impor-
tance of providing comprehensive health and 
social care services that address the many and 
varying needs of adults with CP.
Research in CP has primarily focused on 
management of children with the condi-
tion, but there is now an increased focus on 
adults with CP. In 2019, the National Insti-
tute for Health and Care Excellence (NICE) 
published clinical guidelines for adults with 
CP.10 More recently NICE published quality 
standards, setting out five key areas for quality 
improvement in health services for adults 
with CP.11 Implementation of such guidelines 
and quality standards is expected to increase 
quality of life and functional independence, 
decrease pain, improve participation and 
reduce unplanned hospital admissions.11 
However, current services in the UK fall 
short of these standards, with NICE recently 
reporting that service provision for adults 
with CP is insufficient and lacks continuity 
of care.10 In order to develop and transform 
services for adults with CP, it is important to 
quantify the number and needs of the popu-
lation that will use such services.
The Northern Ireland Cerebral Palsy 
Register (NICPR) is a cross- sectional, 
population- based register of people with CP 
in Northern Ireland born since 1977. Data 
are collected in childhood. The NICPR aims 
to monitor trends in the prevalence of the 
condition, provide a framework for research 
and provide reliable information for service 
planners and providers regarding the needs of 
people living with CP in Northern Ireland.12 
Jonsson et al recently demonstrated that more 
severe CP types such as spastic tetraplegia 
and dyskinesia are less common in adults 
Strengths and limitations of this study
 ► This study used a population- based cerebral palsy 
register that uses multiple sources of ascertainment.
 ► Northern Ireland Cerebral Palsy Register data are 
collected during childhood and thus results are an 
estimate of the condition in adulthood.
 ► Data were only available for those aged under 40 
years.
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than children.13 While the profile of the CP population 
in adulthood may be different to that of childhood, data 
from the NICPR provides population- based estimates of 
numbers and abilities of persons with CP and thus are 
useful for planning care and services.
The purpose of this study was to provide information 
on the prevalence and functional abilities of adults with 
CP born from 1981 to 2001, who were alive and resident 
in Northern Ireland at the time of transitioning to adult 
services, that is, at 19 years of age. Specifically, this study 
aimed to report the prevalence and clinical character-
istics of adults aged 19–39 years with CP in one region 
of the UK to help inform health and social care services 
planning and delivery more generally.
METHOD
Study design and eligibility
This population- based cross- sectional study included all 
validated cases of CP (congenital and acquired) known 
to the NICPR born between 1981 and 2001 and alive and 
resident in Northern Ireland at age 19 years. The sample 
thus constitutes all adults known to the NICPR from the 
register’s first fully ascertained birth year (1981 birth 
cohort, aged 39 years old) through to those who have 
just moved from paediatric services (2001 birth cohort, 
aged 19 years). Those who died, or moved out of the 
region before the age of 19 years, were excluded from 
the sample.
Method of the NICPR
At inception, the NICPR used Mutch et al’s definition 
of CP.14 The definition by Rosenbaum et al has been 
employed since 2007.1 The NICPR adheres to Surveil-
lance of Cerebral Palsy in Europe (SCPE) guidelines and 
processes regarding eligibility and classification of cases.15 
Reliability of the NICPR is demonstrated by multiple 
ascertainment and notification of cases by healthcare 
professionals including paediatricians, physiotherapists, 
occupational therapists and families. In addition, routine 
searches of special education schools and hospital inpa-
tient admission lists help to maximise case ascertainment. 
Each notified case is followed up with a standardised 
assessment booklet, completed by a clinician well known 
to the child, detailing the birth history, clinical character-
istics of the child’s condition and any additional medical 
conditions.16 After the child’s fourth birthday, all assess-
ment booklets are reviewed by the Register’s paediatri-
cian to confirm or refute diagnosis of CP. Children who 
die before the age of 2 years, or who emigrate before the 
age of 3 years, are excluded from the NICPR. Annual 
information on deaths and emigration is received from 
the Northern Ireland Health and Social Care Business 
Services Organisation.
Study variables
CP subtype was classified according to the SCPE defini-
tions as spastic bilateral, spastic unilateral, dyskinetic, 
ataxic and unclassifiable.15 Gross motor function was 
classified using the Gross Motor Function Classification 
System (GMFCS).17 For cases predating publication of 
the GMFCS an algorithm was applied to registry data, 
the validity of which was found to be satisfactory.18 Upper 
limb function was rated using a 4- level system from I (no 
problem) to IV (incapable of eating/dressing). Hearing, 
visual, communication and intellectual impairments were 
reported as being present, not present or uncertain. 
Feeding problems were coded from free- text comments 
as present (eg, being fed via nasogastric tube, percuta-
neous endoscopic gastrostomy in situ, fed orally with 
difficulties or gastro- oesophageal reflux) or not present. 
Seizures, excluding neonatal and febrile seizures, were 
reported as ever having occurred, never having occurred 
or uncertain.
Statistical analysis
The prevalence rate of CP for those born from 1981 to 
2001 was calculated per 1000 population of the same age 
using the Northern Ireland Statistics and Research Agen-
cy’s midyear population estimates. Descriptive statistics 
were used to summarise clinical characteristics and func-
tional ability of the sample. All statistical analyses were 
performed using STATA (V.12.0; StataCorp). In order 
to identify and summarise definite clinical needs, associ-
ated impairments were dichotomised as present or not 
present/uncertain.
Patient and public involvement
Mrs Emma Livingstone (Adult CP Hub) was involved at 
all stages of the study and is coauthor of the paper.
RESULTS
Of the 1369 cases born 1981–2001 (ie, aged 19–39) and 
known to the NICPR, 151 were excluded because they 
had died (n=113) or moved out (n=38) before the age of 
accessing adult services (19 years old). Of those who died 
before transitioning to adult services, 93% (n=105/113) 
were classified as GMFCS levels IV–V and 86% (n=97/113) 
had experienced seizures in the past. Mean age of death 
was 10 years (range 2–19 years). Those who moved out 
of the region prior to transitioning were comparable to 
the sample included in this study, with more than two- 
thirds (68%, 26/38) classified as GMFCS levels I–III. A 
total of 1218 persons with CP aged 19–39 years were thus 
included, 93% (n=1137/1218) of whom were still alive and 
resident in Northern Ireland at the time of this study. The 
remaining 7% (n=81/1218) either died (n=46) or moved 
out (n=35) after accessing adult services (figure 1). Latest 
figures from the Northern Ireland Statistics and Research 
Agency estimated the total population of persons aged 
19–39 years old, living in Northern Ireland in 2019, to be 
511 261.
Prevalence and clinical characteristics of persons with CP 
born 1981–2001 (aged 19–39 years)
The period prevalence of CP (1981–2001) was 2.38 per 
1000 population born during the same period. This rate 
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includes those who transitioned to adult services but have 
since died or emigrated.
This population- based sample of adults with CP aged 
19–39 years, were 56% male (n=683/1218). The majority 
of cases had spastic CP (n=1132/1218, 93%), with 47% 
of those being unilaterally affected (n=535/1132) and 
53% having bilateral involvement (n=597/1132). More 
than three- quarters of the sample could walk inde-
pendently or with the use of a walking aid (GMFCS levels 
I–III, n=949/1218, 78%). The majority of the sample 
(n=833/1218, 68%) had at least one reported associated 
impairment and almost 15% (n=177/1218) had four or 
more reported associated impairments. Additional infor-
mation relating to upper limb function and associated 
impairments can be found in table 1.
Of the 46 cases with CP that died after transitioning to 
adult services, the majority were male (n=30/46, 65%). 
All cases died between 19 and 35 years (n=24 aged <25 
years, n=22 aged 25–35 years), the majority had bilateral 
spastic CP (n=39/46, 85%) and were classified as GMFCS 
levels IV–V (n=40/46, 87%). Underlying cause of death 
(International Classification of Diseases 10th Revision 
(ICD-10 version): 2019)19 was specified as CP in almost 
half of cases (21/46, 47%). In the remaining cases, cause 
of death was categorised from the following ICD-10 cate-
gories: malignant neoplasms, epilepsy, congenital malfor-
mations, other ill- defined and unspecified causes, surgical 
operation with formation of external stoma, and diseases 
of the circulatory, respiratory, digestive and genitourinary 
systems. More granular data cannot be presented as none 
of these ICD-10 categories were notified for more than 
five deaths.
DISCUSSION
This population- based study reported the prevalence and 
clinical characteristics of persons with CP born 1981–
2001 in one region of the UK. It thus represents a cohort 
of younger adults (aged 19–39 years) with CP that require 
ongoing coordination and management of their condi-
tion within adult health and social care services. More 
than 90% of children with CP notified to the NICPR 
survived, or remained in the region and thus transitioned 
from paediatric to adult services. Four per cent of cases 
in this study died in adulthood. The period prevalence of 
CP for 19–39 year olds was 2.38 per 1000 population. The 
majority of cases had spastic CP. Almost a quarter of the 
population used a wheelchair (GMFCS levels IV–V) and 
almost one- third required assistance to eat and/or dress 
or were incapable of eating/dressing themselves. More 
than one- third of cases reported a history of seizures, 
or communication, or intellectual impairments. Over 
25% had some form of visual impairment with smaller 
numbers reporting hearing impairment or feeding diffi-
culties. However, 68% of cases experienced at least one 
associated impairment, with almost 15% experiencing 
four or more associated impairments. Those with multiple 
impairments were considered to have complex health-
care needs. This highlights the diverse range of services 
required for adults with CP.
Figure 1 Flow diagram showing inclusion of participants born during 1981–2001. NICPR, Northern Ireland Cerebral Palsy 
Register.
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The prevalence of CP in adults aged 19–39 years in this 
study was 2.38 per 1000 population the same age, which 
is considerably higher than the rate of 1.14 per 1000 
population recently reported in Sweden.13 However, the 
Swedish study included older adults aged 39–58 years and 
those who were alive and resident at the time of the study. 
In comparison, reliable data were not available for those 
older than 39 years in the current study and the preva-
lence rate included those who were alive and resident at 
19 years, in order to estimate health and social care needs 
at the time of transition to adult services. This finding 
highlights the value of population- based CP registers in 
quantifying the size of the adult CP population in order 
to inform relevant health and social care services. While 
results from this study can be applied to other developed 
countries with similar healthcare systems, there would 
be added value in other long- standing CP registers esti-
mating prevalence of CP in adults.
While the current study included all cases of CP that 
were alive and resident at the time of transition, that is, 
19 years, almost 4% of cases died after transition to adult 
services. Not surprisingly, the majority of those who died 
after the age of 19 years had bilateral spastic CP and were 
classified as GMFCS levels IV–V, thus necessitating signif-
icant resources and services during their time in adult 
services. This finding is supported by a recent Austra-
lian study that demonstrated an increase over time in 
the number of severely impaired young people with CP 
surviving and transitioning to adult services.9 Data from 
population- based registers can be used to help plan for 
future health and social care services for those with more 
severe CP that may require a broad range of specialised 
services.






  Male 683 (56.08)
  Female 535 (43.92)
CP subtype
  Spastic bilateral 597 (49.01)
  Spastic unilateral 535 (43.92)
  Dyskinetic 38 (3.12)
  Ataxic 36 (2.96)
  Unclassifiable 7 (0.57)
  Missing 5 (0.41)
GMFCS level
  I 211 (17.32)
  II 614 (50.41)
  III 124 (10.18)
  IV 87 (7.14)
  V 178 (14.61)
  Missing 4 (0.33)
UL function
  No problem 389 (31.94)
  Some difficulty 443 (36.37)
  Needs help eat/dress 208 (17.08)
  Incapable eat/dress 157 (12.89)
  Missing 21 (1.72)
Seizures
  Ever 426 (34.98)
  Never/Uncertain 681 (55.91)
  Missing 111 (9.11)
Communication
  Yes 465 (38.18)
  No/uncertain 741 (60.84)
  Missing 12 (0.99)
Intellectual
  Yes 490 (40.23)
  No/uncertain 709 (58.21)
  Missing 19 (1.56)
Hearing
  Yes 81 (6.78)
  No/Uncertain 1114 (93.22)
  Missing 23 (1.89)
Vision
  Yes 334 (27.42)
  No/uncertain 879 (72.17)






  Yes 196 (16.09)
  No 951 (78.08)
  Missing 71 (5.83)
Frequency of associated impairments*
  0 385 (31.6)
  1 285 (23.40)
  2 184 (15.11)
  3 187 (15.35)
  4 or more 177 (14.53)
Uncertain: clinician was uncertain as to whether the impairment 
was present or absent, proportion of cases with data coded as 
uncertain ranged from 1.56% for communication impairment to 
7.14% for hearing impairment.
*Frequency of associated impairments included only those 
impairments reported in the table.
CP, cerebral palsy; GMFCS, Gross Motor Function Classification 
System; UL, upper limb.
Table 1 Continued
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Findings from this study estimated the clinical profile 
of adults with CP aged 19–39 years. Comparable to 
previous population- based reports, the majority of cases 
had spastic CP.13 20 Almost a quarter of cases were clas-
sified as requiring a wheelchair, considerably more than 
the 12%–15% of adults with CP reported in previous 
studies.13 20 This is potentially due to differences in registry 
methods for classifying gross motor function. In addition, 
the current study reported seizures in more than one 
third of cases while previous reports ranged from 14% 
to 19%.13 20 Again, this can be explained by differences 
in defining seizures, whereby we included any history of 
seizures whereas others included only those cases having 
treatment or recurring seizures at the time of inclusion 
on the Register. Alternatively, examination of cases that 
died before transitioning to adult services revealed that 
the majority (n=93/113) had experienced seizures in the 
past 12 months, suggesting epilepsy may be a risk factor 
for mortality. Our findings highlight the importance of 
using consistent terminology and definitions to facilitate 
comparisons between countries and regions.
Recent NICE guidelines10 identified the need for 
the development of pathways that allow adults with 
CP to access a comprehensive local network of care. 
Results from this study inform service commissioners 
and providers about the varied healthcare needs of this 
population as almost half of cases reported at least two 
associated impairments. CP is a common neurological 
condition that requires access to services similar to other 
neurological conditions. The prevalence of CP in adult-
hood reported here (2.38 per 1000) is not dissimilar to 
that reported for multiple sclerosis (1.90 per 1000 popu-
lation)21 or Parkinson’s disease (2.85 per 1000 popula-
tion),22 yet health and care services for adults with CP 
are less well established than those for other neurological 
conditions, not equitable across regions and fall short of 
the provision recommended in current guidelines10 and 
standards.11
The needs of people with CP are diverse and, like the 
general population, will change with age, and thus child-
hood data may not accurately reflect characteristics of 
adults with CP. For example, adults with the condition 
experience a decline in mobility earlier than their non- 
disabled peers23 and have increased risk of noncommuni-
cable disease, such as cardiac and respiratory diseases.24 
The NICE guidelines committee suggests that, depen-
dent on local pathways of care, support for adults with CP 
may be adequately provided in primary care settings, with 
regular review.25 Specialist input is required if the clin-
ical impact of the condition becomes more challenging 
for the individual with CP or if a procedure is being 
considered that will impact on the execution of usual 
daily activities. Ensuring that a local pathway is in place 
will enable access to services for adults with CP at a local 
level.10 This may help reduce loss of function, morbidity 
and mortality,13 and thus may be more cost- efficient 
for service providers in the long term. Similarly, a clear 
pathway for specialist referral, when required, would be 
of benefit to both general practitioners, who may be the 
first point of contact, and adults with CP.
Given that findings from this study are based on clin-
ical assessment in childhood, future population- based 
research is required to more accurately establish func-
tional ability, as well as educational attainment and 
employment status in adults with CP. In tandem with 
this, research is needed to further understand current 
provision of services for adults with CP and satisfaction 
with such services. Finally, given that the needs of adults 
with CP are not well understood,9 research is warranted 
to quantify unmet needs in this population. Research 
in these areas is urgently required and would further 
support transformation of care in adults with CP.
The main strength of this study was its use of the 
population- based register. Reliability of the NICPR 
is demonstrated by multiple ascertainment of cases, 
including healthcare professionals and secondary 
searches of routine health and education systems. 
However, the NICPR is cross- sectional in nature and 
provides a snapshot of the condition in childhood. Adults 
with CP experience quicker declining mobility compared 
with the general population,2 3 and those able to walk 
independently as a child may require a wheelchair as an 
adult. Therefore, these results only provide an estimate of 
the clinical profile of adults with CP and may overestimate 
the functional status of adults with CP. In addition, data 
were not available for adults with CP over the age of 39 
years as the earliest reliable birth cohort available on the 
NICPR is 1981. Several variables included in this study, 
namely seizures and feeding, had missing information for 
more than 5% of cases. Further, the reliability of clinician 
reported data on associated impairments is not known, 
however, this is method is typically used internationally 
across registry research programmes.15 Finally, results of 
this study are specific to a geographical region of the UK 
and thus may not be comparable to other regions.
CONCLUSIONS
Findings from this study highlight that population- based 
registers can be used to quantify the number and needs of 
adults with CP. The prevalence of CP in adults is compa-
rable to other common neurological conditions. Adults 
with CP have complex and varied needs that can change 
over time, and thus require access to a diverse range of 
health and care services. Results from this study can be 
used to inform and transform health and care services for 
adults with CP.
Twitter Karen McConnell @KMcConnellQUB and Oliver Perra @oliver_perra
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